Radiation Therapy Protocol Development
A well-designed radiation therapy protocol is critical for:
- Ensuring accurate treatment delivery.
- Reducing the risk of adverse clinical outcomes and unnecessary toxicities.
- Promoting consistency across patients.
- Optimizing outcomes and enabling robust quality assurance.
At Veriray, our disease site experts bring years of experience in developing protocols for various radiation therapy modalities. We collaborate with you from the inception of your trial to uphold the highest standards of radiation therapy, allowing you to focus on the investigational drug.
Radiation Therapy Contouring
Accurate contouring in radiation therapy is essential for:
- Precisely defining the target tumor volume.
- Minimizing radiation exposure to surrounding healthy tissues.
- Maximizing tumor control while reducing side effects.
Veriray ensures radiation is delivered exactly where it is needed most, avoiding unnecessary damage to nearby organs at risk and enhancing treatment effectiveness.
Radiation Therapy Quality Assurance
Quality assurance in radiation therapy is vital to:
- Maintain consistent, accurate, and safe treatment delivery.
- Ensure the validity and reliability of clinical trial data.
- Minimize variability and facilitate accurate comparisons between treatment groups.
The experts at Veriray ensure trial results reflect the true efficacy of the treatment being tested, eliminating errors caused by inconsistencies in radiation delivery.
Toxicity Attribution
Toxicity attribution identifies the cause of adverse events during clinical trials, distinguishing whether they stem from:
- Radiation therapy.
- The investigational drug.
- Other external factors.
Veriray’s scientists utilize existing models or work with you to develop new ones, ensuring accurate attribution and increasing the likelihood of success for study drugs.
Pattern of Failure Analysis
Pattern of failure analysis provides key insights into:
- Recurrence locations, such as in-field, marginal, or out-of-field.
- Treatment effectiveness of the investigational drug.
- Failures attributed to inadequate therapeutic radiation doses.
This analysis helps tailor trials to address specific failure patterns, enhancing therapeutic outcomes and identifying new indications for treatment development.
Veriray 